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ABSTRACT 
Flavonoids are polyphenolic plant secondary metabolites with many purposes, 
including providing pigmentation in plants and anti-oxidant and anti-cancerous activities 
in humans.  There are over 10,000 different flavonoids known, making them one of the 
largest groups of natural products. One major sub-class of flavonoids is the flavan-3-ols, 
which are known for their health benefits and the ability to form proanthocyanidins, or 
condensed tannins.  Many of the intermediates in this pathway are unstable and have not 
been isolated in planta.  Another natural product of interest is sclareol, a diterpene 
alcohol, which is important in the fragrance and flavor industry as a precursor to Ambrox, 
and ambergris analog that can be used as a fixative in high end perfumes. 
In this study we are aiming to create a synthetic complex using a polymer 
nanocarrier to co-localize two sequential enzymes in a pathway.  The first system tried 
included the final two enzymes in flavan-3-ol biosynthesis, anthocyanidin synthase 
(ANS) and anthocyanidin reductase (ANR).  Each of these enzymes, along with the 
preceding enzyme, dihydroflavonol 4-reductase (DFR) has been recombinantly expressed 
in E. coli with a specific tag for binding to the nanocarrier.  However, due to difficulty 
achieving ANS activity a backup system involved in sclareol synthesis was developed.  
Two enzymes, NgCPS and sSsSS, were used to convert geranylgeranyl-pyrophosphate 
(GGPP) to sclareol in a coupled assay.  Each enzyme was purified with either a 6xHis tag 
or monomeric DM3 streptavidin tag for attachment to the nanocarrier.  Assays to measure 
each enzymes activity have been designed, and our goal now is to test each enzyme’s 
activity before and after co-localization onto the nanocarrier.   
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CHAPTER 1: INTRODUCTION 
Flavonoid Pathway 
Flavonoids are one of the largest groups of plant natural products with over 
10,000 known today (Tahara 2007).  They have many functions in plants and benefits to 
human health.  Flavonoids are known to function in plant defense as well as aiding in UV 
protection and attracting polinators (Harborne and Williams 2000; Beecher 2004).   One 
type of flavonoid, anthocyanins, a glycosylated version of anthocyanidin, are the largest 
group of water-soluble pigments known (Yan, Chemler et al. 2005).  These compounds 
are responsible for the bright reds, oranges, and blues found in many flowers and fruits.  
Anthocyanins can be used as a natural alternative to current dyes that may be harmful.  In 
humans and animals flavonoids, and more specifically, flavan-3-ols, have anti-oxidant 
and anti-cancerous properties.  It has also been shown that flavonoids may have anti-
obesity and anti-microbial properties (Chung, Wong et al. 1998; Cos, De Bruyne et al. 
2004; Tsuda, Ueno et al. 2006)).  The upstream pathway has been extensively studied, 
but the later steps need further elucidation (Burbulis and Winkel-Shirley 1999; Pelletier, 
Burbulis et al. 1999).  The natural occurance, applications, and health benefits of 
flavonoids have also been reviewed (Gu, Kelm et al. 2003; Aron and Kennedy 2008).  
However, research involving the flavonoid pathway and possible applications makes this 
field of continued interest to researchers.   
The flavonoid pathway stems from the phenylpropanoid pathway (Figure 1) and 
culminates in the production of flavonols, anthocyanidins, flavan-3-ols, and 
proanthocyanidins, which have a variety of functions as secondary metabolites.   
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As you can see in Figure 1 there are many possible product outcomes of the flavonoid 
pathway.  One such outcome is the formation of proanthocyanidins, or condensed 
tannins, which are polymers of flavan-3-ols.  Proanthocyanidins are responsible for the 
astringent taste in grapes and wine (Bate-Smith 1973).  The branching point for this 
outcome is dihydroflavonol reductase, or DFR, which catalyzes the conversion of 
dihydroquercetin to leucoanthocyanidin (Figure 2).  The intermediates in the last steps of 
this pathway are highly unstable.  Leucoanthocyanidins polymerize readily upon a very 
Figure	  1.	  	  Flavonoid	  biosynthetic	  pathway.	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slight change in environmental conditions.  These flavonoids are then converted to 
anthocyanidin, which contains a flavylium cation by anthocyanidin synthase (ANS), then 
reduced by anthocyanidin reductase, or ANR, to form the final product in this branch of 
the flavonoid pathway--- epicatechin.  Epicatechin, a flavan-3-ol can then polymerize to 
form proanthocyanidins.  Although the flavonoid pathway has been studied for more than 
fifty years the last step in proanthocyanidin synthesis is unknown. 
 
 
Figure	  2.	  Late	  flavonoid	  pathway	  in	  Arabidopsis	  thaliana.	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Flavonoid accumulation first begins in the seed coat of plants when it is exposed 
to UV light (Pelletier, Murrell et al. 1997).  Flavonoid production can increase at any 
time in the plant’s life when exposed to external stress (Winkel-Shirley 2002).  Several 
manipulations of plants have been used to study flavonoids.  For instance, mutations that 
cause a clear to yellow phenotype due to disruption of the production of pigmentation in 
plants, called transparent testa, have been used to identify genes involved in flavonoid 
biosynthesis and map their loci by disrupting the production of plant pigmentation from 
flavonoids (Koornneef 1990; Shirley, Kubasek et al. 1995).  There have also been 24 
mutant knockout studies to analyze anthocyanidin presence during various stages of plant 
growth (Pelletier, Burbulis et al. 1999; Abrahams, Tanner et al. 2002; Abrahams, Lee et 
al. 2003). 
Arabidopsis thaliana has been used by many researchers as a model system to 
study flavan-3-ol biosynthesis.  There are several reasons for this: First, Arabidopsis has 
a fully sequenced genome, which simplifies genetic studies and manipulations.   Also, all 
but one of the enzymes involved in flavan-3-ol biosynthesis are encoded by a single gene 
(Winkel-Shirley 2001).  FLS, the exception, has six naturally occurring gene copies, but 
only one is responsible for activity in wild type plants (Pelletier, Murrell et al. 1997).  
Finally, Arabidopsis thaliana does not appear to encode an equivalent enzyme to 
leucoanthocyanidin reductase (LAR), which helps to further simplify the study of flavan-
3-ol biosynthesis by limiting the product stereochemistry to that of (-)-epicatechin 
(Abrahams, Lee et al. 2003). 
The flavonoid pathway must be carefully regulated due to interactions between 
enzymes and intermediates.  For example, in order for proanthocyanidins to be formed 
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leucoanthocyanidin, the extension unit, must be present in higher concentrations than 
flavan-3-ols, the initiator unit (Abrahams, Lee et al. 2003).  Many of the intermediates in 
this pathway are highly reactive and possibly toxic so they must be rapidly transported 
between enzymes in order to accumulate high levels of end product while keeping 
intermediate concentrations low (Mathews 1993; Ovadi and Srere 1996). 
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Flavonoids 
Structure 
Flavonols are polyphenolic compounds that are derived from phenylalanine and 
acetyl-CoA using the phenylpropanoid pathway.  There are 9 sub-classes of flavonols 
(Figure 3), which include anthocyanidins and flavanols.  The variance in these units 
depends on the placement of the hydroxyl group on the rings.  
Leucoanthocyanidins 
Leucoanthocyanidins are highly reactive intermediates in the flavonoid 
biosynthetic pathway.  These 3, 4-diols are the extension units for proanthocyanidin 
formation.  They have not yet been isolated in nature (Forkmann and Martens 2001), 
which may be because of their tendency to polymerize readily.  The inability to isolate 
these compounds in nature may also be due to highly efficient exchange between the 
enzymes in the possible existence of a flavonoid biosynthetic enzyme complex.  
Leucoanthocyanidins may also convert back to their precursors, dihydroflavonols, under 
storage conditions (Pang, Peel et al. 2007).  Because of their unstable nature, 
Figure	  3.	  	  The	  nine	  recognized	  sub-­‐classes	  of	  flavonoids	  and	  their	  general	  structures.	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leucoanthocyanidins are difficult to measure and generate and must be lyophilized or 
acidified immediately upon synthesis to avoid degradation. 
Anthocyanidins 
Anthocyanidins are the precursor to flavan-3-ols.  They can exist as a flavylium 
cation, but that is uncommon to see in nature.  They usually exist as salts or 
anthocyanins, glycosylated versions of anthocyaninins that are more stable.  The small 
amounts of anthocyanidins found in nature are typically considered to be degradation 
products of anthocyanins (He, Mu et al. 2010).  Anthocyanidins have a pH dependant 
color that varies from blue to red.  Anthocyanins are best known for producing 
pigmentation in plants, which aids in defense against UV light and in the recruitment of 
plant pollinators  (Harborne and Williams 2000).  It has also been shown that the 
administration of blackberry extracts that are rich in anthocyanins to rats will halt tumor 
growth and may even shrink the tumor size (Desai, Olsen et al., 2010).   
Anthocyanidin marks the committed step in the downstream flavonoid pathway 
because it is the substrate for two different enzymes.  UDPglucose:flavonoid 
glucosyltransferase (UGFT) will glycosolate  anthocyanidin to form an anthocyanin, a 
stable product.  Anthocyanidin reductase (ANR) reduces anthocyanidin to a flavan-3-ol. 
Flavan-3-ols 
 Flavan-3-ols are a class of flavonoids that contain a 3-hydroxyl group on the 
central ring (Figure 4).  They possess two chiral carbons, leading to different possible 
stereochemistries.  Flavan-3-ols can be found as single unit monomers, or they can 
condense to form dimers, oligomers, or polymers (Marles, Ray et al. 2003).  These 
flavan-3-ol polymers are often called proanthocyanidins, or condensed tannins. 
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Flavan-3-ols are the most commonly found 
flavonoid in our diet (Scalbert and Williamson 2000).  
They can be found in many foods and beverages 
including vegetables, fruits, tea, cocoa and legumes.  
Food sources rich in flavan-3-ols have become referred to 
as “superfoods” for their high antioxidant activity.  This 
has led to extensive research on flavan-3-ols and sources rich in these beneficial 
compounds.  
It has been demonstrated that flavan-3-ols have anti-microbial/viral activity 
(Chung, Wong et al. 1998).  They may also suppress Staphylococcus aureus resistance to 
antibiotics (Vinson, Mandarana et al. 2002).  It is also known that flavan-3-ol monomers 
from plants rich in these flavonoids are capable of chelating transition metals (i.e. iron or 
lead), which leads to an increased resistance to high concentrations of these metals in the 
environment.  In addition, invasive neighboring plant grown is slowed by (-)-epicatechin 
and (-)-catechin, flavan-3-ol monomers (Ahmad, Gupta et al. 2000; Bais, Vepachedu et 
al. 2003) which are also used in defense against invasive microorganisms (Scalbert, 
1991). 
Another interesting property of flavan-3-ols can be seen in extracts from 
flavonoid rich plants, which show anti-cancerous and cancer preventative effects 
(Grotewold, Lin et al. 2006; Ahmad, Cheng et al. 2000).  The extracts have also been 
shown to induce apoptosis and reduce tumor formation (Cos, De Bruyne et al. 2004; 
Bagchi, Bagchi et al. 2000).  Because of these implications in plant defense and human 
Figure	  4.	  	  	  The	  general	  structure	  of	  a	  flavan-­‐3-­‐ol.	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health, flavan-3-ols have been widely studied.  Future work on flavan-3-ols including 
potential sources and uses of these compounds remains important. 
Proanthocyanidins 
 Proanthocyanidins, or condensed tannins (CTs) are the condensation products of 
flavan-3-ols.  They are well known because their presence in grapes and wine leads to 
astringency.  The astringency occurs because proanthocyanidins react with proline-rich 
proteins in saliva (Kallthraka, Bakker et al. 2001).  It has been speculated that this 
astringency works as a defense mechanism for the 
grapes because it is unpalatable to animals and 
microbes (Bate-Smith, 1973). 
 There are three different proanthocyanidin 
types.  A-type proanthocyanidins have two bonds 
between the flavan-3-ol units, whereas B-type 
proanthocyanidins have only one bond.  Because 
of this, A-type proanthocyanidins confer more 
rigidity than B-type.  Both structures can be seen 
in Figure 5.  The third type of proanthocyanidins is 
C-type, which has a minimum of three units---one 
initiating and at least two extension units 
(Hemingway, Karchesy et al. 1989). 
  Proanthocyanidins have anti-microbial and 
anti-fungal effects in plants (Beecher 2004) but Figure	  5.	  Structure	  of	  A-­‐type	  and	  B-­‐type	  (-­‐)-­‐epicatechin	  dimers	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they are best known for their health benefits in humans, which includes anti-oxidant 
activity as well as cardio and neuro-protective benefits (Aron and Kennedy 2008).  The 
bioavailability of proanthocyanidins has been studied and they are the least absorbed 
class of flavonoids through the digestive track in humans (Tsang, Auger et al. 2005).  It is 
much easier to metabolize flavan-3-ol monomers than oligomers or polymers (Scalbert, 
Deprez et al. 2000; Manach and Donovan 2004).  It is even thought that flavanol 
monomers are not absorbed into the body until they are broken down into smaller 
metabolites (Scalbert 1991; Gonthier et al. 2003). 
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Arabidopsis thaliana flavonoid biosynthetic enzymes 
Dihydroflavonol Reductase 
Dihydroflavonol reductase (DFR) catalyzes the stereo-specific C-4 reduction of a 
dihydroflavonol to leucoanthocyanidin, a 3,4-cis diol as seen in figure 6 (Stafford and 
Lester 1985).  This reaction is the beginning of a series of 
steps in flavan-3-ol biosynthesis with highly unstable 
intermediates.  DFR is classified as a short-chain 
dehydrogenase/reductase and required NADPH as a cofactor 
(Petit, Granier et al. 2007).  The crystal structure obtained 
from grape showed that the substrate is wrapped up by both 
the N- and C- terminals of the enzyme with the NADPH 
binding site located in the N-terminal, which forms a 
characteristic Rossmann fold (Petit, Granier et al. 2007).  
DFR from Arabidopsis thaliana has previously been 
recombinantly expressed and characterized in E. coli 
(Leonard, Yan et al. 2008). 
Anthocyanidin Synthase 
The enzyme that follows DFR in the flavonoid biosynthetic pathway in 
Arabidopsis is anthocyanidin synthase, or ANS.  This enzyme is also referred to as 
leucoanthocyanidin dioxygenase (LDOX) and corresponds to the TDS4 gene (Abrahams, 
Lee et al. 2003).  ANS is a 2-oxoglutarate dependent dioxygenase that requires the 
cofactors 2-oxoglutarate and Fe(II) for activity.  ANS requires the presence of oxygen 
and it has been shown that an unusually high concentration of ascorbate is needed to 
Figure	  6.	  	  Reaction	  catalyzed	  by	  DFR	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increase the activity of this enzyme to its 
maximum catalytic rate. AtANS has been 
purified and crystallized and the structure can 
be seen in figure 7 (Turnbull, Prescott et al. 
2001).   
ANS catalyzes the oxidation of flavan-
3,4-diols to anthocyanidins, the step after DFR 
in the flavonoid biosynthetic pathway.  Both 
the main substrate and product of ANS are 
relatively unstable.  Also, there have been studies into the stereospecificity of this 
enzyme and the products formed.  In vitro assays have shown that leucoanthocyanidin 
stereochemistry affects the product outcome with ANS catalyzing either the formation of 
dihydroquercetin or cyanidin.  ANS also catalyzes the conversion of dihydroquercetin to 
quercetin after a second catalytic cycle (Turnbull, Nagle et al. 2003).  The various 
reactions ANS catalyzes can be seen in figure 8.  In further studies ANS was found to 
form a cyanidin in the direct flavan-3-ol pathway (Turnbull, Sobey et al. 2000).  It should 
be noted that there are complications with ANS characterization due to substrate and 
product instability, the compounds forming complexes with the Fe(II) and further levels 
of oxidation.  This leads to indirect evidence for the true mechanism and products of 
ANS.  Using the natural 2,3 cis form of leucoanthocyanidin it was observed that 
quercetin was the most prevalent product of ANS (85% of the product profile) whereas 
cyanidin was the least prevalent product, accounting for only 2% (Turnbull, Sobey et al. 
2000). 
Figure	  7.	  	  Crystal	  structure	  of	  AtANS,	  complexed	  with	  narigenin.	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Anthocyanidin Reductase 
Anthocyanidin reductase, or ANR is the last step in flavan-3-ol biosynthesis.  This 
enzyme converts anthocyanidin to a flavan-3-ol (Figure 9), and is also dependent on 
NADPH.  ANR resides in the BANYULS gene in 
arabidopsis.  It has been shown that when this gene is 
mutated there is an accumulation of red anthocyanin 
pigments and loss of proanthocyanidins (Xie, Sharma et 
al. 2003).  In Arabidopsis thaliana ANR catalyzes the 
formation of (-)-epicatechin from cyanidin (Xie, Sharma 
et al. 2003).  A full characterication of AtANR 
recombinantly expressed in E. coli has been performed 
alongside ANR from Medicago trucatula (Xie, Sharma 
et al. 2004). 
Figure	  8.	  	  The	  reactions	  catalyzed	  by	  anthocyanidin	  synthase.	  
Figure	  9.	  	  The	  reaction	  catalyzed	  by	  ANR	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Backup platform: sclareol synthesis 
In the event that the flavonoid biosynthesis system would not work with the 
experimental design, a backup platform with similar applications to the flavor and 
fragrance industry was chosen.  Ambergris, waxy substance secreted by the sperm whale, 
has long been used as a fixative in high-end perfumes.  It is well known for its musky and 
sweet earthy scent, but its use has become 
controversial due to the fact that the only natural 
source is an endangered and protected animal species 
(Caniard and Zerbe 2012).  Ambergris is in short 
supply and has undergone price inflation, so a 
number of ambergris substitutes have been developed 
(Schalk and Pastore 2012).   One such substitute is Ambrox (Figure 10), which is 
industrially produced by semisynthesis from sclareol, a naturally occurring diterpene 
alcohol (Gunnewich and Higashi, 2012). 
Sclareol has been reported in four different plant species: Salvia sclarea, Cistus 
creticus, Nicotiana glutinosa,and Cleome spinosa (Caniard and Zerbe 2012).  The main 
plant based source of sclareol is the flowers and leaves of Salvia sclarea (Clary sage), a 
biennial herb native of Southern Europe.  However, despite successful cultivation of 
Clary sage, annual production and availability of sclareol varies substantially due to 
uncontrollable environmental factors (Caniard and Zerbe 2012).  Thus, the development 
of an alternative, cost-effective and sustainable way to produce sclareol is desirable. 
In plants diterpenes are derived from geranylgeranyl diphosphate (GGPP) through 
cyclization reactions catalyzed by diterpene synthases.  Two types of cyclization 
Figure	  10.	  	  Chemical	  structure	  of	  Ambrox,	  an	  ambergris	  analog.	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mechanisms occur in nature, which are separated into two classes of diterpene synthases: 
class I and class II, both of which are Mg2+ dependent.  Class II diterpene cyclases are 
catalyzed by the protonation dependent cyclization of GGPP, forming a bicyclic 
diphosphate intermediate, and Class I diterpene cyclases are initiated by ionization of the 
diphosphate ester (Peters 2010).  Sclareol is produced via diterpene synthesis and can be 
synthesized by specific diterpene cyclases. 
A class II diterpene synthase from Nicotiana glutinosa (NgCPS) is known to 
catalyze the reaction of GGPP to labda-13-en-8-ol diphosphate (LDPP) (Guo and Wagner 
1995; Shepard 2002).  Sclareol synthase has been successfully cloned and functionally 
characterized and the sclareol synthesis pathway had been reconstructed in recombinant 
e. coli (Schalk and Pastore 2012), so the LDPP produced by NgCPS will be converted to 
sclareol by sclareol synthase from Sclarea sativa (sSsSS) as seen in Figure 11.   
In this proposed backup platform NgCPS and sSsSS could be expressed and 
purified from e. coli with several different tags to be used for co-localization onto a 
nanoparticle to increase yields of sclareol, an important compound in the flavor and 
fragrance industry. 
 
Figure	  11.	  	  Sclareol	  synthesis	  from	  geranylgeranyl	  diphosphate	  (GGPP).	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Enzyme Attachment 
Enzyme attachment to a platform has many potential benefits to a biological 
process.  The process can be made more efficient for commercial or industrial scale, and 
can be manipulated as such (Sheldon 2007).   Immobilization may increase the stability 
of the enzyme being used, which can increase performance and percent recovery of the 
enzyme (Cabral and Kennedy 1993).  Also, this stability may include higher tolerance to 
extreme pH or temperature ranges, as well as other conditions. 
Lactose dehydrogenase and glucose dehydrogenase have been tethered to silica 
glass platforms (El-Zahab, Jia et al. 2004) and there were differences in the generation 
and use of the cofactor, NADH, between the two enzymes with variations in the chain 
length.  Liu, Zhang, et al. 2009 duplicated this experiment using glutamate 
dehydrogenase in the place of glucose dehydrogenase, and both showed high turnover 
and regeneration of NADH. 
There has been little related research concerning the biosynthesis of flavan-3-ols 
or sclareol.  Leucoanthycyanidins have been immobilized and stabilized (Deffieux, 
Gaudrel-Grosay et al. 2009) but no instance of enzyme stabilization has been reported.  
However, similar benefits should be expected by using enzyme attachment with these 
systems as long as no negative interactions occur. 
The aim is to co-localize two enzymes using a Nickel-6xHistidine binding and 
Biotin-Streptavidin binding to provide control over the placement and ratios of the 
enzymes in question to determine if any of the expected benefits to the system are present 
(Figure 12).  The enzymes to be attached include Anthocyanidin synthase and 
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Anthocyanidin reductase, or Nicotiana glutinosa ent-copalol diphosphate synthase and 
Sclareol synthase in the event that active flavonoid biosynthesis protein cannot be 
obtained. 
 
 
 Figure	  12.	  	  Enzyme	  attachment	  scheme	  for	  ANS	  and	  ANR.	  	  The	  same	  scheme	  would	  apply	  for	  NgCPS	  and	  sSsSS.	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Hypothesis 
The objective of this project is to create a more efficient or stable synthetic 
flavan-3-ol biosynthetic complex that will mimic the proposed flavonoid multi-enzyme 
complex.  The aim of this research is to attach several enzymes in the late flavonoid 
biosynthetic pathway to a nanocarrier via site-specific attachments.  The enzymes that 
will be attached to this nanocarrier catalyze the last steps in the biosynthesis of flavan-3-
ols, which are compounds that have many benefits to human health as well as a plethora 
of other purposes as plant secondary metabolites. 
The enzymes of interest will be purified and their activity assayed both before and 
after site-specific attachment to a nanocarrier.  The attachment will occur by expressing 
each enzyme with a fusion tag that has specific binding for sites on the surface of the 
nanocarrier.  The platforms that will be used are a 6xHistidine tag that will covalently 
bind to nickel on the surface of the nanocarrier, and a monomeric streptavidin tag that 
will specifically bind to biotin on the nanocarrier.  These platforms can be attached to the 
nanocarrier concurrently or sequentially to control for the ratio of one enzyme to the 
other. 
Co-localizing these enzymes onto a nanocarrier will be beneficial to the pathway 
in several ways.  First, the attachment could stabilize the protein and allow it to withstand 
environments that it would not be able to in solution.  This could help the protein remain 
active in harsh environments and avoid denaturation.  Also, attaching sequential proteins 
could lead to intermediate shuttling between the enzymes allowing for a more efficient 
system of two or more enzymes.  This intermediate shuffling would also avoid loss of 
substrate due to diffusion and unwanted side reactions. 
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CHAPTER 2: MATERIALS AND METHODS 
Materials 
Geranylgeranyl-pyrophosphate (GGPP) standard was purchased from 
Isoprenoids, LC (Tampa, FL).  Standards for HPLC analysis (dihydroquercetin, 
quercetin, cyanidin chloride, and (-)-epicatechin) and all other reagents, substrates, and 
chemicals were purchased from Sigma-Aldrich (St. Louis, MO).  C41(DE3) chemically 
competent cells were purchased from Lucigen (Middleton, WI) for protein expression.  
Top10 competent cells were purchased from Invitrogen (Carlsbad, CA).  All DNA 
primers were synthesized by Invitrogen or the DNA facility of Iowa State University’s 
Office of Biotechnology.  Accuprime Pfx polymerase was ordered from Invitrogen.  
Takara Primestar HS Polymerase was ordered from Fischer Scientific (Waltham, MA). 
DNA Cloning and Recombination 
Native AtANR was obtained from the TAIR database.  Amino acid sequences for 
AtDFR and AtANS were taken from the TAIR database and were codon optimized for 
growth in E. coli and synthesized into pUC57 (Genscript USA Inc.).  A monomeric 
streptavidin tag was placed on the N-terminus of AtANS with a (glycine3-serine1)4 linker 
in between the amino acid sequences of the tag and AtANS. 
Accuprime Pfx polymerase (Invitrogen) was used for PCR of AtANR with an 
initial melting temperature of 95°C for 5 minutes, then 30 seconds at 94°C, 62°C for 30 
seconds and an elongation time of 2 minutes at 72°C for 34 cycles, followed by 7 minutes 
at 72°C and 10 minutes at 4°C.  AtANS and AtDFR were cloned using Takara Primestar 
HS polymerase (Fischer Scientific).  Both genes were clones using the Primestar 2-step 
method with an elongation time of 2.5 minutes for AtANS and 1.75 minutes for AtDFR.  
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The primers used were ordered from Invitrogen and diluted to 5 nmol concentrations.  
They can be seen in Table 1.  DNA gel electrophoresis was used to determine and isolate 
the correct gene using a 1.5% agarose gel.  The DNA band with the appropriate size was 
purified by a Millipore DNA gel purification kit and confirmed with full genetic 
sequencing. Table	  1.	  	  Primers	  used	  in	  cloning	  PCR,	  5’	  to	  3’	  
	   Forward Reverse 
AtDFR CACCATGGTGTCCCAAAAAGAAACGGTG TCAAGCACACATCTGTTGCGCCAGCATC 
AtANS GGGACAAGTTTGTACAAAAAAGCAGGCTTCGAAGGA
GATAGAACCATGGACCCGAGCAAAGACAG 
GGGGACCACTTTGTACAAGAAAGC
TGGGTCTTAATCATTTTTTTCAGA
CA 
AtANR CACCATGGACCAGACTCTTACACACACCGGATCG CACCTCATTTAGCTTTGATCAATCCTTTTGACTC 
 
Using the SD/D TOPO enzyme from Invitrogen’s Gateway® recombination 
system AtDFR and AtANR DNA fragments were inserted into pENTR by following 
protocol.  The BP clonase enzyme from the Gateway® system was used to insert AtANS 
into pDONR221 by following protocol.  All three were transformed using Top10 cells 
(Invitrogen) and propagated onto 1.5% agarose NZY medium plates with 50 µg/mL 
kanamycin for antibiotic resistance selection.  AtANR was inserted into the destination 
vector pDest17, and both AtANS and AtDFR were inserted into pDest15 and AtANS was 
also cloned into pDest14 using the Gateway® LR clonase enzyme following protocol.  
They were then transformed into Top10 cells for DNA propagation.  pDest14 contains no 
tag, pDest15 contains an N-terminal GST tag, and pDest 17 contains an N-terminal Ni2+ 
tag. 
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NgCPS in the entry vector pENTR had been previously made by the Peters Lab 
and was obtained and cloned into pDest17.  sSsSS in pDest17 had been previously made 
by the Peters Lab and was also obtained.  Accuprime Pfx polymerase (Invitrogen) was 
used to clone out NgCPS, sSsSS, and DM3 (from DM3-sAtANS) with 19 bp overhangs 
to add the DM3 tag to the insert for future attachment to the nanoparticle.  Primers used 
for cloning can be seen in Table 2.  After addition of the DM3 tag, NgCPS-DM3 and 
sSsSS-DM3 were sequence verified and cloned into pDest15 for expression. 
 
Primer Sequence 
DM3-F CACCATGGACCCGAGCAAAG 
DM3-R TCAACCGCCACCACTGCC 
DM3-NgCPS-R GCTTACCTGAATATCCATCGGAACCGCCACCACTGC 
DM3-NgCPS-F GCAGTGGTGGCGGTTCCGATGGATATTCAGGTAAGC 
DM3-sSsSS-F GTGGCAGTGGTGGCGGTTCCGATGGCAAAAATGAAAGAA 
DM3-sSsSS-R TTCTTTCATTTTTGCCATCGGAACCGCCACCACTGCCAC 
 
Protein Expression 
For protein expression of DFR, ANS, ANR, NgCPS, and sSsSS the genes were 
transformed to C41 (DE3) cells.  50 µg/mL carbenicillin was included for antibiotic 
selection during each step of the expression process.  One colony from the transformation 
was selected to inoculate 5 mL NZY media starter cultures and shaken at 200 rpm at 
37°C overnight.  They were enlarged to 50 mL NZY media at 37°C for two hours then 
Table 2. Primers used to add DM3 tag to NgCPS and sSsSS 	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transferred to 1L NZY media and allowed to grow to an optical density of 0.6-0.8 A600.  
The cells were then allowed to equilibrate at 16°C for 1 hour before they were induced by 
the addition of 1 mM isopropyl-β-thiogalactopyranoside (IPTG).  The cells were left to 
shake overnight for a total induction time of 16 hours. 
Cells were harvested by centrifuging the media at 5,000 g for 20 minutes at 4°C.  
The supernatant was discarded and the cell pellet was re-suspended in lysis buffer (50 
mM Bis-Tris, pH 6.8, 150 mM KCl, 10 mM MgCL2, 10 % glycerol for 6xHis tagged 
protein or 20 mM Tris-HCl pH 7.0, 200 mM NaCl, 1 mM EDTA, 1 mM β-
mercaptoethanol for other applications).  The re-suspended cells in lysis buffer were 
lysed by sonication (3 x 8 s continuous output at 30 % amplitude).  The lysed cells were 
clarified by centrifugation at 15,000 g for 20 minutes at 4°C. 
Protein Purification 
AtDFR (42800.6 Da) was purified using glutathione-agarose resin (Sigma-
Aldrich).  1 mM Triton®X-100 was added to the clarified cell lysate containing 
pDest15/AtDFR (70,155 kDa) before incubation with 3 mL resin (50% v/v in PBS-T) on 
a rotisserie at 4°C for 1-2 hours.  The glutathione-agarose resin was prepared by swelling 
the lyophilized powder in sterile water overnight at 200 mL/g on a rotisserie at 4°C.  The 
agarose beads were then washed thoroughly with 10 volumes of equilibration buffer 
(PBS-T) before incubation with the clarified cell lysate.  1 mM dithiothreitol (DTT), 0.1 
mM ethylenediaminetetraacetic acid (EDTA), and 0.1 mM phenylmethylsulfonyl fluoride 
(PMSF) were added during incubation and to each following step. 
After the incubation period, resin was collected by spinning at 1,000 rpm for 5 
minutes in a clinical centrifuge at 4°C.  The supernatant and each following wash were 
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collected for SDS-PAGE analysis.  The resin was re-suspended in 5 mL PBS-T and 
collected as described previously.  This wash step was repeated 3 times.  The resin was 
then re-suspended in a final wash and transferred to a mini column under gravity flow 
and the wash was allowed to flow through and collected.  10 mL of elution buffer (10 
mM reduced glutathione in 50 mM Tris-HCl, pH 9.5) was added to the column and the 
eluate was collected and analyzed by SDS-PAGE.  The purified protein was quantified by 
A280 using the GST-tagged AtDFR extinction coefficient of 85,930 M-1cm-1. 
AtANS (with GST tag: 83902.28 Da; without: 57902.28 Da) with the GST tag 
was purified following the same protocol as AtDFR.  ANS lysate with no tag was 
purified on an AKTA FPLC system using a Mono Q HR 5/5 (GE Healthcare) column.  
Buffers used are as follows: buffer A was 50 mM Bis-Tris buffer and buffer B was 50 
mM Bis-Tris and 3 M NaCl, both pH 6.8. The method is as follows: 0-4 minutes at 2% 
buffer B, 4-14 minutes gradient to 10% buffer B, 14-17 minutes at 100% buffer B. Flow 
rate was 1 mL/ min with 0.5 mL fractions collected, all at 4˚C.  Final protein was 
quantified by A280 using the GST-tagged AtANS extinction coefficient of 126 110 M-1 cm 
-1 and 84 950 M-1 cm -1 with no GST tag. 
AtANR (38,745 Da) was purified using Ni-NTA resin (Sigma-Aldrich).  3 mL 
resin (50% v/v in bind buffer: 50 mM NaH2PO4, pH 8.0, 300 mM NaCl, 10 mM 
imidazole) was incubated with the clarified lysate containing pDest17/AtANR for 1-2 
hours at 4°C on a rotisserie.  1 mM DTT was added during the incubation period and to 
each additional step.  The resin was collected as described previously and washed 3 times 
with wash buffer (50 mM NaH2PO4, pH 8.0, 300 mM NaCl, 20 mM imidazole).  The 
resin was then re-suspended in a final wash and transferred to a mini column under 
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gravity flow and the wash was allowed to flow through.  10 mL of elution buffer (50 mM 
NaH2PO4, pH 8.0, 300 mM NaCl, 250 mM imidazole) was added to the column and the 
eluate was collected and analyzed by SDS-PAGE.  The purified protein was quantified by 
A280 using the extinction coefficient of 31,750 M-1cm-1 for pDest17/AtANR. 
NgCPS and sSsSS in pDEST17 followed the same purification procedure as 
17/ANR.  NgCPS and sSsSS with the DM3 tag were cloned into pDest15, and followed 
the same purification procedure as for DFR and ANS.  Constructs made along with their 
molecular weights and extinction coefficients used to verify the correct size via SDS-
PAGE and concentration of constructs can be seen in Table 3. 
 
Protein construct Molecular weight Extinction coefficient 
GST-NgCPS-DM3 128251.53 216670 M-1cm-1  
6xHis-NgCPS 83637.72 126720 M-1cm-1  
GST-DM3-sSsSS 106049.15 164710 M-1cm-1  
6xHis-sSsSS 61304.15 74760 M-1cm-1  
 
Activity Assays 
AtDFR assays consisted of 100 mM Tris-HCl pH 7.0, 2 mM NADPH, and 100 
µM dihydroquercetin (DHQ) in 1 mL final volume.  100 µg purified protein was added to 
the reaction, which was incubated at 37°C for 30 minutes and then stopped with 1 mL 
ethyl acetate extraction.  The extraction was repeated two times for a final volume of 3 
mL.  Each extraction was mixed by vortexing for 1 minute, and any emulsions were 
broken by centrifugation at 3,000 rpm in a clinical centrifuge.  The final extract was dried 
Table	  3.	  	  Sclareol	  synthase	  constructs,	  molecular	  weights,	  and	  extinction	  coefficients.	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under nitrogen gas and the residual was dissolved in an n-butanol/HCl (95%/5% v/v) 
solution and incubated at 95°C for 30 minutes as described (Stafford and Lester 1980) to 
convert the unstable leucocyanidin to cyanidin.  The cyanidin concentration was then 
analyzed by UV absorption at 550 nm to determine enzymatic activity. 
AtANS assays were designed to measure the conversion of dihydroquercetin 
(DHQ) to quercetin.  Each contained 100 mM MOPSO, pH 6.2, 20 mM ascorbate, 160 
µM 2-oxoglutarate, 40 µM FeSO4, 0.1 mg/mL bovine serum albumin, 10 µL catalase, 800 
µM DHQ and varying amounts of enzyme in a total volume of 1 mL.  Assays were 
incubated at 37°C for 10 minutes to 1 hour and stopped with the addition of 25 µL formic 
acid.  Any precipitate was cleared by centrifugation at 3,000 rpm in a clinical centrifuge.  
100 µL of the acidified assay was analyzed on an Agilent 1200 series HPLC with an 
Eclipse C18-reverse phase column (150 mm X 4.6 mm; bead size, 5 µm, Agilent).  The 
method is as follows: 0-10 min 10%-40% acetonitrile, 10-15 min 40%-10% acetonitrile 
with 1% formic acid throughout. 
To test the activity of AtANR an assay was designed to measure the conversion of 
cyanidin chloride to epicatechin.  The assay contained 100 mM Tris-HCl, pH 7.0, 2 mM 
NADPH, 100 µM cyanidin chloride, and 100 µg purified protein in a total volume of 1 
mL.  Each assay was incubated at 37°C for 30 minutes and stopped with ethyl acetate.  
The assay was extracted with 3 x 1 mL ethyl acetate as described previously and the 
extracts were dried under nitrogen.  They were then re-dissolved in 30 µL methanol for 
HPLC analysis using the same procedure as previously described with a 25 µL injection. 
Sclareol synthase assays used a coupled assay procedure to test for the conversion 
of GGPP to sclareol.  50 uM GGPP was dried under nitrogen, then the following assay 
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constituents were added to the final concentration indicated: 50 mM HEPES pH 7.4, 5 
mM MgCl2, 10 % glycerol, 100 mM KCl, 5 mM DTT, and H2O to 1 mL.  The reaction 
mixture was incubated at 30°C for 10 minutes before addition of NgCPS and sSsSS.  
Upon enzyme addition the assay was briefly vortexed and incubated for 1 hour at 30°C.  
The reaction was stopped with 3 x 1 mL hexane extraction.  The assay extract was dried 
under nitrogen and re-suspended in 50 µL hexane before running on the GC-FID to 
quantify the amount of sclareol produced and GC-MS to verify sclareol as the product 
formed. 
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CHAPTER 3: RESULTS AND DISCUSSION 
Arabidopsis thaliana Flavonoid biosynthetic enzymes 
 DFR was expressed because of the stability 
and availability of its substrate.  Leucoanthocyanidin, 
the substrate for ANS, is unstable and cannot be 
purchased.  By including DFR in the system 
leucoanthocyanidin could be produced, lyophilized, 
and stored at -80°C for future assays.  Alternatively, 
DFR could be included in the assay mixture bound to 
glutathione resin along with dihydroquercetin to 
make leucoanthocyanidin for the immobilized ANS 
then removed via centrifugation. 
 DFR was successfully purified from E. coli 
using glutathione resin.  Correct protein size was 
confirmed via SDS-PAGE, and the amount of 
purified protein was quantified using the extinction 
coefficient of 85,930 M-1cm-1.  Activity was confirmed using the previously stated assay 
procedure to determine cyaniding concentration at 550 nm.  Note the pink color observed 
in Figure 13, which shows a successful DFR assay.  DFR activity was retained after 4+ 
months storage at -80°C and can be used as a way to produce ANS substrate in future 
assays. 
 ANR was designed to be able to be immobilized with a Ni-6xHis attachment, 
which is why it was cloned into and expressed in the pDest17 vector.  ANR was 
Figure	  13.	  	  Successful	  DFR	  assay	  with	  purified	  enzyme	  and	  no	  enzyme	  control	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expressed, purified, 
and quantified 
using the extinction 
coefficient 31,750 
M-1cm-1.  Purified 
protein size was 
verified via SDS-
PAGE.  To test the 
activity of ANR the 
turnover from 
cyanidin to 
epicatechin was 
measured.  
Cyanidin has a 
maximum 
absorbance of 550 
nm, whereas 
epicatechin has an absorbance at 280 nm.  ANR assays were performed as previously 
described and run on the HPLC to verify activity by epicatechin production (Figure 14).  
ANR was shown to retain activity after storage at -80°C for several months, and should 
be able to be used in future assays with ANS and DFR included. 
 When e. coli optimized ANS was ordered it was designed with an N-terminal 
monomeric streptavidin tag, DM3, that was separated from the enzyme with a (glycine3-
Figure	  14.	  	  HPLC	  chromatograms	  of	  ANR	  assay	  including	  substrate	  and	  product	  standards	  at	  280	  nm:	  A.	  cyanidin	  chloride	  standard.	  	  B.	  	  	  epicatechin	  standard.	  	  C.	  	  ANR	  assay	  extract	  showing	  the	  assay	  product,	  epicatechin,	  formation	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serine1)4 linker to provide flexibility between the nanoparticle and the enzyme.   ANS 
was first purified using the GST tagged pDest15 vector.  Purified protein was quantified 
using the extinction coefficient of 126 110 M-1 cm -1, and protein size was verified by 
SDS-PAGE.  The ANS activity assay was extremely difficult to replicate and ANS 
showed little or no activity in most purifications.  To optimize the assay and consistently 
achieve ANS activity a range of different assay conditions was attempted.  pH ranges 
from 6.0-8.0 were tested using several different buffer systems (HEPES, MOPS, MES, 
Tris-HCl) and the best pH was found to be 6.5.  However, even at this pH ANS activity 
(measured by turnover of DHQ to quercetin on the HPLC) was rarely seen and not at all 
consistent.  The ANS sequence was double checked and found to be correct, and the 
protein that was purified was 
consistent with the expected 
GST-DM3-ANS size.  To 
determine if either the GST-tag 
or addition of DM3 was 
causing the lack of ANS 
activity each was removed 
individually and both were 
removed altogether leaving only 
the ANS sequence which is known to be active (Turnbull et al., 2000).  Following the 
previously described protocol the enzyme was cloned into pDest14 both with and without 
the DM3 tag and purified via FPLC (Figure 15), but no activity could be seen in either 
case.  After several months of attempting to purify an active form of ANS with no 
Figure	  15.	  	  FPLC	  chromatogram	  of	  ANS	  purification	  without	  DM3	  tag.	  	  Red	  arrow	  indicates	  ANS	  protein	  verified	  by	  SDS-­‐PAGE.	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success it was decided that work should be started on the backup sclareol synthase 
system. 
Backup system: sclareol synthase 
 NgCPS and sSsSS were expressed with several combinations of the DM3 and 
6xHis tag to provide flexibility in attachment to the nanoparticle.  NgCPS was expressed 
and purified with both an N-terminal 6xHis tag and a C-terminal DM3 tag.  sSsSS was 
also expressed and purified 
with an N-terminal 6xHis tag 
and a C-terminal DM3 tag as 
well as an N-terminal DM3 tag.   
Activity of each construct was 
verified by setting up coupled 
assays and running the assay 
extracts on the GC-FID and 
GC-MS to detect sclareol.  
Figure 16 shows a sclareol 
standard run on the GC-FID as 
well as a successful coupled 
assay extract.  First, the N-
terminal 6xHis tagged enzymes 
were coupled to test activity of the native enzymes with no manipulations.  After activity 
was shown with this 6xHis tag the DM3 tagged constructs were introduced.  NgCPS 
showed the highest activity with the N-terminal 6xHis tag, although the C-terminal DM3 
Figure	  16.	  	  Top:	  GC-­‐FID	  chromatogram	  of	  a	  1	  mM	  sclareol	  standard.	  	  Bottom:	  	  GC-­‐FID	  chromatogram	  of	  a	  coupled	  NgCPS	  and	  sSsSS	  assay.	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tag showed limited activity as well.  To keep future work simplified only 6xHis tagged 
NgCPS was used to test sSsSS constructs.  sSsSS showed efficient sclareol production 
with the 6xHis tag as well as both the N- and C-terminal DM3 tags.   
The GC-FID peak areas for several preparations of sSsSS can be seen in Table 4.  
Each sample was also run on the GC-MS to verify that sclareol was produced.  These 
results indicate that the NgCPS and sSsSS sclareol synthase system can be used while 
moving forward with the enzyme co-localization.   
 
 
After activity was confirmed in both NgCPS and sSsSS with separate tags, the 
next step was to purify large amounts of the protein constructs for future use in testing 
enzymatic activity before and after co-localization onto the nanoparticle.  Table 5 shows 
the constructs prepared and concentrations after purification.  Each purification was 
stored at -80°C for future testing.  The constructs will be tested both before and after co-
localization onto the nanocarrier to determine if co-localization increases the product 
yield, specifically by measuring the formation of sclareol. 
Table	  4.	  	  GC-­‐FID	  data	  of	  coupled	  NgCPS	  and	  sSsSS	  assays	  with	  various	  constructs	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Table	  5.	  	  Final	  sclareol	  synthase	  constructs	  purified	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CHAPTER 4: CONCLUSION 
 The aim of this project was to develop a system of multiple sequential enzymes 
with tags for attachment onto a nanoparticle platform.  It is thought that this co-
localization might lead to increased output of the desired product by keeping the enzymes 
in close proximity to each other in the reaction mixture.  This could occur by reduction of 
unstable intermediate side reactions and by intermediate shuttling that kinetically favors 
product formation by the enzymes.  In order to test these effects, a system of two or more 
enzymes with several fusion tags to be developed, expressed and purified.  Also, there 
needed to be a way to measure and compare product formation before versus after 
immobilization to quantify the results of co-localization. 
Two biosynthetic pathways with applications towards human health and the flavor 
and fragrance industry were investigated.  The first system, involved in flavonoid 
biosynthesis, was chosen because the pathway has been well characterized.  The end 
products, flavan-3-ols, have been shown to have anti-cancerous and anti-oxidant 
properties in humans.  Thus, creating an efficient system to express and purify the 
enzymes involved for co-localization onto a nanocarrier is desirable as a way to 
industrially synthesize large amounts of the beneficial compounds.  The second system 
investigated involves the synthesis of sclareol, a compound that has applications in the 
flavor and fragrance industry as a precursor to ambrox, an analog of ambergris, which has 
long been used as a fixative in high-end perfumes but has become expensive and has 
limited availability. 
The enzymes of interest for each pathway were obtained and manipulated to have 
one of two tags for attachment onto a nanocarrier: either an N-terminal 6xHis-tag or a 
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monomeric streptavidin tag, DM3.  Once the correct constructs were obtained they were 
cloned into E. coli, expressed, and purified.  The purified proteins were then tested in 
assays that were developed and optimized to measure the conversion of substrate to 
product. 
The first system attempted was the flavonoid system, where the sequential 
enzymes anthocyanidin synthase (ANS) and anthocyanidin reductase (ANR) would be 
attached to the platform, and dihydroflavonol reductase would be included in the reaction 
mixture to convert dihydroquercetin to leucoanthocyanidin, the unstable substrate for the 
ANS/ANR system.  ANS would be expressed with a DM3 tag for attachment, and ANR 
would include a 6xHis tag.  Unfortunately, this flavonoid system did not work 
collectively due to difficulties achieving activity in ANS.  DFR and ANR were purified 
with high activity even after several months storage at -80°C, but even after a year of 
work attempting to achieve consistent activity in ANS using several different constructs 
and purification methods, the lack of promising progress led to a project transition to 
work on the sclareol synthase backup system. 
The backup system was much more straightforward to work with.  Within a short 
time frame consistent activity in coupled assays was achieved with several different 
combinations of tags for enzyme attachment.  NgCPS, the first enzyme in the sclareol 
synthesis system showed high activity with an N-terminal His-tag, and moderate activity 
with a C-terminal monomeric streptavidin tag, DM3.  Sclareol synthase, or sSsSS, also 
showed high activity with an N-terminal His-tag and constructs with an N- and C-
terminal DM3 tag showed good activity as well.  This enables the enzymes to be co-
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localized onto a nanoparticle platform with control over attachment method and 
placement, as well as the ratios of enzymes attached. 
Several milligrams of each sclareol synthase construct have been prepared for 
future work on this project.  The next step is to test the enzymes activity before and after 
attachment to a nanoparticle to compare the product yields.  Different combinations of 
tagged enzymes can be used to compare the attachment methodologies and test for 
differences between the constructs that have been made and their relative activities.  The 
data collected using the purified proteins that have been made should add to current 
information known about how enzymes interact when they are attached to a platform and 
any benefits this attachment may provide.  In the larger scale this technique could be used 
for more efficient production of compounds of interest by increasing the product yield 
using the strategies that have been outlined.  A working system which enables future 
work to study these possibilities has been developed and will be employed to gain 
valuable insight into the interactions and benefits of a multiple enzyme system co-
localized onto a nanoparticle platform. 
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